LTR Medical is pleased to announce that CitraFlow™ Prefilled Syringes have gained TGA approval. CitraFlow™ 4%, 30% and 46.7% prefilled syringes are a proven alternative to heparin for flushing and locking catheters/ports on patients. Sodium citrate avoids the risks associated with systemic heparinisation and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia. Clinical studies have shown that the use of ananticoagulant Sodium Citrate solution to lock central venous catheters has significant advantages compared to existing standards of care. CitraFlow™ is highly effective in maintaining catheter patency, works as an anticoagulant and decreases the incidence of infection. CitraFlow™ is designed for use in a sterile field. For more information, visit our product page MedXL - LTR Medical or call us on 1800 319 419

LTR Medical is proud to announce that with TGA approval we will move to the next stage in launching the SAFIRA™ - SAFer Injection for Regional Anaesthesia in the Australian and New Zealand markets. Manufactured by Medovate, the SAFIRA™ gives Anaesthetists control over regional anaesthesia blocks by making it a single operator procedure.  With an engineered safety solution to control injection pressure threshold, it reduces the change of nerve injury. LTR Medical CEO Lee Rodne commented: “The team at LTR Medical are excited to introduce the SAFIRA® to the Australian and New Zealand Markets. This groundbreaking new technology gives Anaesthetists greater control when placing nerve blocks and reduces the chance of nerve damage, improving patient outcomes.” For further information, visit our product page or call us on 1800 319 419.

LTR Medical has concluded a distribution agreement with Medovate, the medical device development company which will provide exclusivity for SAFIRA® (SAFer Injection for Regional Anaesthesia) in Australia and New Zealand. Developed in collaboration with anaesthetists in the UK National Health Service (NHS), SAFIRA® is set to help revolutionise standard regional anaesthesia clinical practice. With the use of regional anaesthesia continuing to grow significantly in Australia and New Zealand, SAFIRA® has the potential to make a significant impact. Amid the current COVID-19 pandemic, recent publications have recommended regional anaesthesia be considered whenever surgery is planned for a suspected or confirmed COVID-19 patient. This is because regional anaesthesia preserves respiratory function and avoids aerosolisation and the potential for transmission of COVID-19 compared to general anaesthesia. Already launched across the United States, this distribution agreement to bring SAFIRA® to market in Australia and New Zealand marks a significant further step in making this [...]

With tick season upon us, one of the most common serious problems in dogs, the Springfusor may be the way for you to deliver Tick Anti-Toxin easily and accurately. Whilst the Springfusor and FCT is very effective for the delivery of antibiotics and medications to humans, we also have a number of veterinary clinics throughout Australia using it for the delivery of Tick Anti-Toxin. The Springfusor is a reusable spring-driven infusion pump that is used in conjunction with Flow-Control Tubing (FCT).  The FCT controls the rate of delivery and is available in a range of flow rates. For more information please contact our customer service number on 1800 319 419 or visit our product page https://www.ltrmedical.com/springfusor-and-fct-range/

LTR Medical is proud to announce its exclusive agreement with Ammut Medical LCC to distribute the MICROi Blade (MiB).  The MiB was developed in conjunction with Associate Professor Peter Hebbard from Victoria Australia and is set to revolutionise the Micro Invasive Surgical technique space. The initial clinical experience with the MiB, for minimally invasive ultrasound guided carpal tunnel release in an office practice setting, thus far have been outstanding. Patients walk out post procedure with a band aid in contrast to a 3-4 cm incision and stiches with the standard open procedure. Carpal Tunnel Syndrome can affect 3-8% of the adult population and is of particular concern for the aging population. The ability to complete this procedure with a minimal micro invasive technique could revolutionise the surgical management of the Syndrome. Our clinical team is excited at the prospect of facilitating the training for new clinicians across Australia and will be working [...]